FDA-Approved Bone Graft Materials
FDA-approved bone graft materials are covered as medically necessary for enhancement of bone healing.
ONE or more of the following FDA-approved bone graft materials
Demineralized bone matrix (DBM)
Infuse® rhBMP-2: Anterior or Posterior Cervical Fusion
Infuse® Bone Graft (recombinant human bone morphogenetic protein-2 [rhBMP-2]) is considered medically necessary for anterior or posterior cervical fusion when ALL of the following criteria are met.
ALL of the following
Member does not have any known contraindications, including pregnancy or hypersensitivity/allergy.
Performed for an associated approved spinal fusion.
Member has ONE of the following conditions that would place the individual at high risk of fusion failure without rhBMP-2
Occipitocervical pathology
Infuse® rhBMP-2: Stand-Alone ALIF
Infuse® Bone Graft (rhBMP-2) is considered medically necessary for a stand-alone anterior lumbar interbody fusion (ALIF) when ALL of the following criteria are met.
ALL of the following
Performed for an associated approved stand-alone anterior lumbar interbody fusion (ALIF).
The individual does not have any known contraindications, including pregnancy or hypersensitivity/allergy.
Member is skeletally mature.
Infuse® rhBMP-2: PLF, PLIF, or TLIF
Infuse® Bone Graft (rhBMP-2) is considered medically necessary for posterolateral lumbar fusion (PLF), posterior lumbar interbody fusion (PLIF), or transforaminal lumbar interbody fusion (TLIF) when ALL of the following criteria are met.
ALL of the following
No known contraindications, including pregnancy or hypersensitivity/allergy.
Performed for an associated approved spinal fusion.
There is a high risk of fusion failure due to ONE or more of the following clinical scenarios
High risk for fusion failure using traditional autogenous bone grafting in a planned revision spinal fusion for pseudoarthrosis following previous failed spinal fusion.
High risk for fusion failure using traditional autogenous bone grafting in a spinal fusion in a compromised graft bed (e.g., prior radiation therapy).
Infuse® rhBMP-2: Tibial Fractures
Infuse® Bone Graft (rhBMP-2) is considered medically necessary in the surgical repair of an acute, open tibial shaft fracture when BOTH of the following criteria are met.
ALL of the following
Fracture is stabilized with intramedullary (IM) nail fixation.
rhBMP-2 is applied within 14 days of the fracture.within 14 days
PMMA or Calcium Antibiotic Beads
PMMA antibiotic beads or calcium sulfate antibiotic beads are medically necessary when used in conjunction with intravenous antibiotics in the treatment of chronic osteomyelitis.
ALL of the following
PMMA antibiotic beads or calcium sulfate antibiotic beads are used.
Used in conjunction with intravenous antibiotics.
Treatment is for chronic osteomyelitis.
Bone Marrow Injections
Bone marrow injections are medically necessary in the treatment of bone cysts (unicameral/simple).
ALL of the following
Treatment is for a unicameral/simple bone cyst.
Hydroxyapatite Bone Substitute
Hydroxyapatite bone substitute is medically necessary for middle ear surgery.
ALL of the following
Hydroxyapatite bone substitute is used for middle ear surgery.
Beta Tri-Calcium Phosphate-Based Bone Graft Products
Beta tri-calcium phosphate (b-TCP)-based bone graft extenders and substitutes are medically necessary for spinal fusions.
ALL of the following
Beta tri-calcium phosphate (b-TCP)-based bone graft extender or substitute is used.
The procedure is a spinal fusion.
Infuse® Bone Graft is experimental and investigational for all other indications, including its use in ankle fusions and cervical fusions, because its effectiveness for indications other than the ones listed above has not been established.
SummaCare considers all other bone and tendon graft substitutes experimental and investigational because there is insufficient evidence to support their use for these indications.